Medical Xpress news
Medical Xpress / Potential gene therapy for late-stage Parkinson's side-effects uncovered
Northwestern Medicine scientists have discovered that suppressing excitatory synaptic transmission in a small group of neurons in the brain may reverse levodopa-induced dyskinesia in patients with late-stage Parkinson's disease ...
Medical Xpress / Beyond the brain: Organs help shape the nervous systems that control them
A new Yale study reveals that major organ systems in the body aren't just passive structures operating on directions from command central—the brain—but instead are active participants in controlling their own functions.
Medical Xpress / We do not have a decider in our brain: Cognitive neuroscientist challenges theories of decision-making
There is a disconnect between what we think happens when we make a decision and what actually happens in the brain during that process, suggests Indiana University Professor of Psychological and Brain Sciences Tom James. ...
Medical Xpress / New antibiotic kills drug-resistant bacteria by targeting previously unknown vulnerability
Researchers at McMaster University have discovered a new antibiotic that kills some of the world's most dangerous and drug-resistant bacteria—and does so by targeting a previously unknown vulnerability, opening the door to ...
Medical Xpress / New CAR T treatment opens door for patients in need of kidney transplant
A pioneering clinical trial has successfully enabled two patients with end-stage kidney disease to receive previously improbable kidney transplants. These individuals were considered among the most difficult in the nation ...
Medical Xpress / AI misses cancer drug target, revealing why lab validation still matters
Researchers at the Icahn School of Medicine at Mount Sinai have identified a previously hidden druggable site in a cancer-related protein that could open the door toward the development of a new generation of more precise ...
Medical Xpress / Popular GLP-1 drug may slow down biological aging, analysis indicates
Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease. Some researchers have ...
Medical Xpress / Cancer researchers present advances and emerging treatments
Cancer researchers highlighted several treatment breakthroughs during their annual summit in Chicago that concluded Tuesday, including preliminary but encouraging data on potential benefits of weight loss medications.
Medical Xpress / New insights into how autistic and non-autistic people learn about one another
New research from the George Washington University has yielded some unexpected insights into how autistic and non-autistic people learn about one another's preferences. The study indicates that both groups rely on similar ...
Medical Xpress / Novel vaccine adjuvant could make it easier to eradicate polio
In the United States, children routinely receive an injectable form of the polio vaccine. This vaccine is very effective at preventing illness, but it doesn't block transmission of the polio virus as well as the oral polio ...
Medical Xpress / 2.2 million-cell atlas reveals how genes drive inflammatory bowel disease risk
Scientists have created the most detailed cell map to date showing how genetic variation influences inflammatory bowel disease (IBD), revealing the specific cells and genes that drive the disease. Published in Nature, the ...
Medical Xpress / Engineered Salmonella deliver cancer-killing viruses, shrinking liver and pancreatic tumors in mice
Researchers at the University of Massachusetts Amherst have designed non-toxic Salmonella bacteria to deliver viruses that are safe to humans but potent against liver and pancreatic cancer tumors—two cancers with an extremely ...